Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Operating Leases: 2018-2024

Historic Operating Leases for Fresenius Medical Care AG (FMS) over the last 7 years, with Q4 2024 value amounting to $120.6 million.

  • Fresenius Medical Care AG's Operating Leases fell 1608.27% to $120.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $120.6 million, marking a year-over-year decrease of 1608.27%. This contributed to the annual value of $122.2 million for FY2024, which is 1500.34% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Operating Leases stood at $120.6 million for Q4 2024, which was down 1608.27% from $143.7 million recorded in Q4 2023.
  • Fresenius Medical Care AG's Operating Leases' 5-year high stood at $166.9 million during Q4 2020, with a 5-year trough of -$599.2 million in Q3 2020.
  • Its 5-year average for Operating Leases is -$56.0 million, with a median of $128.5 million in 2021.
  • Per our database at Business Quant, Fresenius Medical Care AG's Operating Leases surged by 2267.44% in 2020 and then plummeted by 1826.38% in 2021.
  • Fresenius Medical Care AG's Operating Leases (Quarter) stood at $166.9 million in 2020, then dropped by 18.26% to $136.5 million in 2021, then rose by 14.92% to $156.8 million in 2022, then fell by 8.35% to $143.7 million in 2023, then dropped by 16.08% to $120.6 million in 2024.
  • Its last three reported values are $120.6 million in Q4 2024, $143.7 million for Q4 2023, and $156.8 million during Q4 2022.